118 related articles for article (PubMed ID: 6157649)
1. Effect of a bleomycin derivative on oral carcinoma. A clinical and immunologic study of five cases.
Sakuda M; Hiura S; Usui M; Sugi M; Nukata J; Miyazaki T
Int J Oral Surg; 1980 Apr; 9(2):103-12. PubMed ID: 6157649
[TBL] [Abstract][Full Text] [Related]
2. Effect of bleomycin on squamous cell carcinoma: preliminary observations.
Van Rooyen CE; Haldane EV
N S Med Bull; 1972 Oct; 51(5):144-50. PubMed ID: 4116503
[No Abstract] [Full Text] [Related]
3. The effects of intra-arterial bleomycin therapy on squamous cell carcinoma of the oral cavity. Biopsy and autopsy examinations.
Burkhardt A; Höltje WJ
J Maxillofac Surg; 1975 Dec; 3(4):217-30. PubMed ID: 54400
[TBL] [Abstract][Full Text] [Related]
4. [Clinical effects of NK 631, a new bleomycin derivative, in treatment of oral cancer (author's transl)].
Kajiyama M; Dohjyo M; Ohno A; Nagasaka K; Yamaguma M; Okabe T; Terasaka S
Jpn J Antibiot; 1979 Jan; 32(1):129-37. PubMed ID: 84883
[TBL] [Abstract][Full Text] [Related]
5. [Use of bleomycin in patients with incurable carcinoma of the oral cavity].
Fries R; Wilfert KH
Osterr Z Erforsch Bekampf Krebskr; 1973; 28(1):29-32. PubMed ID: 4123658
[No Abstract] [Full Text] [Related]
6. [Clinical application of NK 631 in the treatment of cancer of the tongue and the floor of the mouth (author's transl)].
Hayashida K; Watanabe H; Ito M; Nakashima T; Toriya Y; Hiroto I; Jingu K; Hayabuchi N
Jpn J Antibiot; 1979 Apr; 32(4):509-15. PubMed ID: 88531
[No Abstract] [Full Text] [Related]
7. Peplomycin-induced apoptosis in oral squamous carcinoma cells depends on bleomycin sensitivity.
Okamura H; Morimoto H; Haneji T
Oral Oncol; 2001 Jun; 37(4):379-85. PubMed ID: 11337271
[TBL] [Abstract][Full Text] [Related]
8. [Continuous subcutaneous infusion of peplomycin in oral squamous carcinoma].
Kanazawa H; Takahashi K; Hanazawa Y; Uchiyama S; Takahara T; Takahara M; Muto M; Kinehara M; Sato K
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 1):775-80. PubMed ID: 2469396
[TBL] [Abstract][Full Text] [Related]
9. [Long-term prognosis of oral squamous cell carcinoma histologically judged to have been eliminated by the treatment with bleomycin alone].
Amagasa T; Shioda S; Iwaki H; Yokoo E; Sato T; Sato K; Tachibana T; Michi K; Shimizu M
Gan No Rinsho; 1985 Mar; 31(3):231-5. PubMed ID: 2582157
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of intratumoral bleomycin application in a tumor model and in a clinical pilot study].
Fröhlich M; Henke E; Gens J; Seela W; Franke WG
Dtsch Z Mund Kiefer Gesichtschir; 1990; 14(6):456-62. PubMed ID: 1725668
[TBL] [Abstract][Full Text] [Related]
11. [Intraarterial bleomycin therapy on squamous cell carcinomas of the oral cavity. Clinico-pathological investigations (author's transl)].
Höltje WJ; Burkhardt A; Gebbers JO; Maerker R
Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1976 Dec; 88(1):69-90. PubMed ID: 64041
[TBL] [Abstract][Full Text] [Related]
12. [Anticancer chemotherapy apropos of bleomycin].
Miyake H; Suzuki Y; Kunishige N
Rev Laryngol Otol Rhinol (Bord); 1972; 93(11):677-89. PubMed ID: 4123695
[No Abstract] [Full Text] [Related]
13. Combined treatment with radiation and bleomycin for intra-oral carcinoma. A preliminary report.
Tanaka Y; Wada T; Fuchihata H; Makino T; Inoue T
Int J Radiat Oncol Biol Phys; 1976; 1(11-12):1189-93. PubMed ID: 62741
[No Abstract] [Full Text] [Related]
14. Synchronized combination bleomycin-methotrexat in regional chemotherapy of orofacial carcinomas.
Bilder J; Hornová J
Neoplasma; 1974; 21(3):335-42. PubMed ID: 4138497
[No Abstract] [Full Text] [Related]
15. [Clinical effects of NK 631 in malignant tumors of the oral cavity (author's transl)].
Kawahira K; Dohhara Y; Sugihara K; Yamada K; Fujinami Y; Saku T; Yamashita S
Jpn J Antibiot; 1979 Jan; 32(1):138-48. PubMed ID: 84884
[No Abstract] [Full Text] [Related]
16. The integration of chemotherapy into a combined modality approached to cancer therapy. V. Squamous cell cancer of the head and neck.
Goldsmith MA; Carter SK
Cancer Treat Rev; 1975 Jun; 2(2):137-58. PubMed ID: 52406
[No Abstract] [Full Text] [Related]
17. Immunity suppression by bleomycin-methotrexate combined treatment in patients with epidermoid carcinoma of the oral cavity.
Bitter K
J Maxillofac Surg; 1974 Mar; 2(1):35-9. PubMed ID: 4133357
[No Abstract] [Full Text] [Related]
18. [MTX-BLM therapy for squamous cell carcinoma of the oral cavity].
Yamamoto E; Kohama G; Kumagai S; Chujyo H; Sonoda A
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2496-501. PubMed ID: 6210051
[TBL] [Abstract][Full Text] [Related]
19. [Formation of giant cells in oral squamous cell carcinoma during bleomycin treatment: enzymehistochemical, electronmicroscopic and ultrahistochemical investigations (author's transl)].
Burkhardt A; Bommer G; Gebbers JO; Höltje WJ
Virchows Arch A Pathol Anat Histol; 1976 Feb; 369(3):197-214. PubMed ID: 56803
[TBL] [Abstract][Full Text] [Related]
20. Effects of sequential administration of bleomycin in combination with mitomycin C on squamous cell carcinoma of oral regions.
Shingaki S; Kawasaki T; Nagamine T; Kanamaru T; Yokobayashi T; Nakajima T
J Oral Surg; 1980 Dec; 38(12):886-92. PubMed ID: 6160232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
